A study to evaluate the severity of gastrointestinal bleeding in obese vs. non-obese veterans taking Direct oral anticoagulants (DOACs)
Latest Information Update: 22 Dec 2021
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary)
- Indications Thromboembolism
- Focus Adverse reactions
Most Recent Events
- 22 Dec 2021 New trial record
- 27 Oct 2021 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021